Majdan Marek, Lingsma Hester F, Nieboer Daan, Mauritz Walter, Rusnak Martin, Steyerberg Ewout W
Department of Public Health, Trnava University, Faculty of Health Sciences and Social Work, Univerzitne namestie 1, Trnava, 91701, Slovakia.
International Neurotrauma Research organization (INRO), Moelkergasse 4/3, Vienna, A-1080, Austria.
Scand J Trauma Resusc Emerg Med. 2014 Nov 19;22:68. doi: 10.1186/s13049-014-0068-9.
External validation on different TBI populations is important in order to assess the generalizability of prognostic models to different settings. We aimed to externally validate recently developed models for prediction of six month unfavourable outcome and six month mortality.
The International Neurotrauma Research Organization - Prehospital dataset (INRO-PH) was collected within an observational study between 2009-2012 in Austria and includes 778 patients with TBI of GCS < = 12. Three sets of prognostic models were externally validated: the IMPACT core and extended models, CRASH basic models and the Nijmegen models developed by Jacobs et al - all for prediction of six month unfavourable outcome and six month mortality. The external validity of the models was assessed by discrimination (Area Under the receiver operating characteristic Curve, AUC) and calibration (calibration statistics and plots).
Median age in the validation cohort was 50 years and 44% had an admission GSC motor score of 1-3. Six-month mortality was 27%. Mortality could better be predicted (AUCs around 0.85) than unfavourable outcome (AUCs around 0.80). Calibration plots showed that the observed outcomes were systematically better than was predicted for all models considered. The best performance was noted for the original Nijmegen model, but refitting led to similar performance for the IMPACT Extended, CRASH Basic, and Nijmegen models.
In conclusion, all the prognostic models we validated in this study possess good discriminative ability for prediction of six month outcome in patients with moderate or severe TBI but outcomes were systemically better than predicted. After adjustment for this under prediction in locally adapted models, these may well be used for recent TBI patients.
对不同的创伤性脑损伤(TBI)人群进行外部验证很重要,以便评估预后模型在不同情况下的通用性。我们旨在对最近开发的预测六个月不良结局和六个月死亡率的模型进行外部验证。
国际神经创伤研究组织-院前数据集(INRO-PH)是在2009年至2012年于奥地利进行的一项观察性研究中收集的,包括778例格拉斯哥昏迷量表(GCS)≤12的TBI患者。对三组预后模型进行了外部验证:IMPACT核心模型和扩展模型、CRASH基本模型以及由雅各布斯等人开发的奈梅亨模型——所有这些模型均用于预测六个月不良结局和六个月死亡率。通过区分度(受试者操作特征曲线下面积,AUC)和校准(校准统计量和图表)来评估模型的外部有效性。
验证队列的中位年龄为50岁,44%的患者入院时GSC运动评分为1-3分。六个月死亡率为27%。与不良结局(AUC约为0.80)相比,死亡率能得到更好的预测(AUC约为0.85)。校准图显示,对于所有考虑的模型,观察到的结局在系统上都比预测的要好。原始的奈梅亨模型表现最佳,但重新拟合后,IMPACT扩展模型、CRASH基本模型和奈梅亨模型的表现相似。
总之,我们在本研究中验证的所有预后模型在预测中度或重度TBI患者的六个月结局方面都具有良好的区分能力,但结局在系统上比预测的要好。在对本地适用模型中的这种预测不足进行调整后,这些模型很可能适用于近期的TBI患者。